TY - JOUR
T1 - Recommendations for Responsible Development and Application of Neurotechnologies
AU - Goering, Sara
AU - Klein, Eran
AU - Specker Sullivan, Laura
AU - Wexler, Anna
AU - Agüera y Arcas, Blaise
AU - Bi, Guoqiang
AU - Carmena, Jose M.
AU - Fins, Joseph J.
AU - Friesen, Phoebe
AU - Gallant, Jack
AU - Huggins, Jane E.
AU - Kellmeyer, Philipp
AU - Marblestone, Adam
AU - Mitchell, Christine
AU - Parens, Erik
AU - Pham, Michelle
AU - Rubel, Alan
AU - Sadato, Norihiro
AU - Teicher, Mina
AU - Wasserman, David
AU - Whittaker, Meredith
AU - Wolpaw, Jonathan
AU - Yuste, Rafael
N1 - Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Springer Nature B.V.
PY - 2021/12
Y1 - 2021/12
N2 - Advancements in novel neurotechnologies, such as brain computer interfaces (BCI) and neuromodulatory devices such as deep brain stimulators (DBS), will have profound implications for society and human rights. While these technologies are improving the diagnosis and treatment of mental and neurological diseases, they can also alter individual agency and estrange those using neurotechnologies from their sense of self, challenging basic notions of what it means to be human. As an international coalition of interdisciplinary scholars and practitioners, we examine these challenges and make recommendations to mitigate negative consequences that could arise from the unregulated development or application of novel neurotechnologies. We explore potential ethical challenges in four key areas: identity and agency, privacy, bias, and enhancement. To address them, we propose (1) democratic and inclusive summits to establish globally-coordinated ethical and societal guidelines for neurotechnology development and application, (2) new measures, including “Neurorights,” for data privacy, security, and consent to empower neurotechnology users’ control over their data, (3) new methods of identifying and preventing bias, and (4) the adoption of public guidelines for safe and equitable distribution of neurotechnological devices.
AB - Advancements in novel neurotechnologies, such as brain computer interfaces (BCI) and neuromodulatory devices such as deep brain stimulators (DBS), will have profound implications for society and human rights. While these technologies are improving the diagnosis and treatment of mental and neurological diseases, they can also alter individual agency and estrange those using neurotechnologies from their sense of self, challenging basic notions of what it means to be human. As an international coalition of interdisciplinary scholars and practitioners, we examine these challenges and make recommendations to mitigate negative consequences that could arise from the unregulated development or application of novel neurotechnologies. We explore potential ethical challenges in four key areas: identity and agency, privacy, bias, and enhancement. To address them, we propose (1) democratic and inclusive summits to establish globally-coordinated ethical and societal guidelines for neurotechnology development and application, (2) new measures, including “Neurorights,” for data privacy, security, and consent to empower neurotechnology users’ control over their data, (3) new methods of identifying and preventing bias, and (4) the adoption of public guidelines for safe and equitable distribution of neurotechnological devices.
KW - Agency
KW - Bias
KW - Enhancement
KW - Identity
KW - Privacy
KW - Public policy
UR - http://www.scopus.com/inward/record.url?scp=85105462329&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85105462329&partnerID=8YFLogxK
U2 - 10.1007/s12152-021-09468-6
DO - 10.1007/s12152-021-09468-6
M3 - Article
AN - SCOPUS:85105462329
SN - 1874-5490
VL - 14
SP - 365
EP - 386
JO - Neuroethics
JF - Neuroethics
IS - 3
ER -